Progesterone and testosterone modulate the convulsant actions of pentylenetetrazol and strychnine in mice

Pharmacology and Toxicology

Volumn 87, Issue 3, 2000, Pages 116-119

  Pesce, Maria Ester ^a   Acevedo, Ximena ^b   Bustamante, Diego ^b   Miranda, Hugo F ^b   Pinardi, Gianni ^b  

^a UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PENTETRAZOLE; PROGESTERONE; STRYCHNINE; TESTOSTERONE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; DIESTRUS; DRUG EFFECT; ESTRUS; FEMALE; MALE; MORTALITY; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; ORCHIECTOMY; PRIORITY JOURNAL; PROESTRUS;

EID: 0033798680     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.pto870303.x     Document Type: Article

References (24)

1. Aprison, M. H., K. B. Lipkowitz & J. R. Simon: Identification of a glycine-like fragment on the strychnine molecule. J. Neurosci. Res. 1987, 17, 209-213.
2. Backstrom, T., B. Zetterlund, S. Blom & M. Romano: Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta neurol. scand. 1984, 69, 240-248.
3. Bitran, D., R. J. Hilvers & C. K. Kellog: Ovarian endocrine status modulates the anxiolytic potency of diazepam and the efficacy of gamma-aminobutyric acid-benzodiazepine receptor-mediated chloride transport. Behav. Neurosci. 1991, 105, 653-662.
4. A receptors. J. Neuroendocrinol. 1995, 7, 171-177.
5. Bitran, D. & J. A. Dowd: Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology 1996, 125, 65-73.
6. A receptors. Eur. J. Pharmacol. 1997, 325, 1-7.
7. Frye, C. A.: The neurosteroid 3 alpha, 5 alpha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 1995, 696, 113-120.
8. Frye, C. A. & L. E. Bayon: Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha, 5 alpha-THP. Neuroendocrinology 1998, 68, 272-278.
9. Frye, C. A. & L. E. Bayon: Cyclic withdrawal from endogenous and exogenous progesterone increases kainic acid and perforant pathway induced seizures. Pharmacol. Biochem. Behav. 1999, 62, 315-321.
10. Galli, R., S. Michelini, L. Bartalena, R. Massetani, L. Pani, L. Grasso, G. B. Cassano, E. Martino, R. H. Purdy & L. Murri: Circulating levels of anticonvulsant metabolites of progesterone in women with partial epilepsy in the intercritical phase. Ital. J. Neurol. Sci. 1996, 17, 277-281.
11. Herzog, A. G.: Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 1995, 45, 1660-1662.
12. Herzog, A. G.: Psychoneuroendocrine aspects of temporolimbic epilepsy. Part I. Brain, reproductive steroids and emotions. Psychosomatics 1999a, 40, 95-101.
13. Herzog, A. G.: Psychoneuroendocrine aspects of temporolimbic epilepsy. Part II. Epilepsy and reproductive steroids. Psychosomatics 1999b, 40, 102-108.
14. A receptor in fetal rat forebrain. Brain Res. Der. Brain Res. 1998, 108, 131-137.
15. A receptor binding. Pharmacol. Biochem. Behav. 1992, 43, 441-447.
16. Korneyev, A. & E. Costa: Allopregnanolone (THP) mediates the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology 1996, 30, 37-43.
17. Pesce, M. E., X. Acevedo, G. Pinardi & H. F. Miranda: Gender difference in diazepam withdrawal syndrome in mice. Pharmacology & Toxicology 1994, 75, 353-355.
18. Pesce, M. E., X. Acevedo, G. Pinardi & H. F. Miranda: Progesterone modulation of diazepam withdrawal syndrome in mice. Pharmacology & Toxicology 1996, 79, 331-333.
19. Reddy, D. S. & S. K. Kulkarni: Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice. Meth. Find. Exp. Clin. Pharmacol. 1997, 19, 395-405.
20. Rupprecht, R., C. A. Hauser, T. Trapp & F. Holsboer: Neurosteroids: molecular mechanism of action and psychopharmacological significance. J. Steroid Biochem. Mol. Biol. 1996, 56, 163-168.
21. Schachter, S. C.: Hormonal considerations in women with seizures. Arch. Neurol. 1988, 45, 1267-1270.
22. Schumacher, M. & E. E. Baulieu: Neurosteroids: synthesis and functions in the central and peripheral systems. Ciba Found. Symp. 1995, 191, 90-106.
23. Wilson, M. A. & R. Biscardi: Influence of gender and brain region on neurosteroid modulation of GABA responses in rats. Life Sci. 1997, 60, 1679-1691.
24. Zimmerman, A. W: Hormones and epilepsy. Neurol. Clin. 1986, 4, 853-861.